Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-04

Clinical Trial Update: The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease [NA]

View source ↗

Summary

A clinical trial update shows recruitment is ongoing for a study evaluating silkworm pupa powder to improve nutritional status and frailty in patients with moto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silkworm Pupa Powder

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Motor Neuron Disease (MND), Amyotrophic Lateral Sclerosis (ALS) | NA | Status: RECRUITING